The University of Chicago Header Logo

Connection

James Liao to Nitric Oxide Synthase Type III

Back to Details
This is a "connection" page, showing publications James Liao has written about Nitric Oxide Synthase Type III.
James Liao
Connection Strength
3.411
Nitric Oxide Synthase Type III
  1. Neuroprotection Mediated by Upregulation of Endothelial Nitric Oxide Synthase in Rho-Associated, Coiled-Coil-Containing Kinase 2 Deficient Mice. Circ J. 2018 03 23; 82(4):1195-1204.
    View in: PubMed
    Score: 0.646
  2. Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protection. Expert Rev Neurother. 2009 Aug; 9(8):1171-86.
    View in: PubMed
    Score: 0.359
  3. Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. Circ Res. 2008 Aug 15; 103(4):360-8.
    View in: PubMed
    Score: 0.333
  4. Dynamic regulation of endothelial NOS mediated by competitive interaction with alpha-actinin-4 and calmodulin. FASEB J. 2008 May; 22(5):1450-7.
    View in: PubMed
    Score: 0.322
  5. Regulator of G-Protein Signaling 5 Maintains Brain Endothelial Cell Function in Focal Cerebral Ischemia. J Am Heart Assoc. 2020 09 15; 9(18):e017533.
    View in: PubMed
    Score: 0.194
  6. Impaired Cognitive Performance in Endothelial Nitric Oxide Synthase Knockout Mice After Ischemic Stroke: A Pilot Study. Am J Phys Med Rehabil. 2018 07; 97(7):492-499.
    View in: PubMed
    Score: 0.167
  7. Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury. Vasc Med. 2012 Dec; 17(6):379-85.
    View in: PubMed
    Score: 0.112
  8. Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ Res. 2008 Sep 12; 103(6):591-7.
    View in: PubMed
    Score: 0.084
  9. Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection. J Cereb Blood Flow Metab. 2008 Jul; 28(7):1285-93.
    View in: PubMed
    Score: 0.082
  10. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci U S A. 2006 Sep 19; 103(38):14104-9.
    View in: PubMed
    Score: 0.074
  11. Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J Clin Invest. 2006 Feb; 116(2):334-43.
    View in: PubMed
    Score: 0.070
  12. Rho GTPases, statins, and nitric oxide. Circ Res. 2005 Dec 09; 97(12):1232-5.
    View in: PubMed
    Score: 0.070
  13. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke. 2005 Oct; 36(10):2251-7.
    View in: PubMed
    Score: 0.068
  14. Induction of angiogenesis by heat shock protein 90 mediated by protein kinase Akt and endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2004 Dec; 24(12):2238-44.
    View in: PubMed
    Score: 0.064
  15. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 2004 Oct; 24(10):1842-7.
    View in: PubMed
    Score: 0.064
  16. Nontranscriptional actions of the glucocorticoid receptor. J Mol Med (Berl). 2003 Mar; 81(3):168-74.
    View in: PubMed
    Score: 0.058
  17. Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells. Arterioscler Thromb Vasc Biol. 2003 Feb 01; 23(2):198-203.
    View in: PubMed
    Score: 0.057
  18. Functional interaction of endothelial nitric oxide synthase with a voltage-dependent anion channel. Proc Natl Acad Sci U S A. 2002 Oct 01; 99(20):13108-13.
    View in: PubMed
    Score: 0.056
  19. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation. 2002 Jul 02; 106(1):57-62.
    View in: PubMed
    Score: 0.055
  20. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2002 May; 8(5):473-9.
    View in: PubMed
    Score: 0.054
  21. Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation. 2002 Mar 19; 105(11):1368-73.
    View in: PubMed
    Score: 0.054
  22. Targeting Rho in cardiovascular disease. Circ Res. 2000 Sep 29; 87(7):526-8.
    View in: PubMed
    Score: 0.049
  23. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem. 1998 Sep 11; 273(37):24266-71.
    View in: PubMed
    Score: 0.042
  24. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1998 Jul 21; 95(15):8880-5.
    View in: PubMed
    Score: 0.042
  25. Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice. Circulation. 2010 Mar 09; 121(9):1104-12.
    View in: PubMed
    Score: 0.023
  26. Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor. Can J Physiol Pharmacol. 2008 Sep; 86(9):633-42.
    View in: PubMed
    Score: 0.021
  27. Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. J Cereb Blood Flow Metab. 2007 May; 27(5):998-1009.
    View in: PubMed
    Score: 0.018
  28. Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies. Life Sci. 2006 Jan 25; 78(9):943-9.
    View in: PubMed
    Score: 0.017
  29. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab. 2005 Jun; 25(6):722-9.
    View in: PubMed
    Score: 0.017
  30. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res. 2004 Jul 23; 95(2):217-23.
    View in: PubMed
    Score: 0.016
  31. Targeting eNOS for stroke protection. Trends Neurosci. 2004 May; 27(5):283-9.
    View in: PubMed
    Score: 0.016
  32. Preservation of NO production by statins in the treatment of heart failure. Cardiovasc Res. 2003 Nov 01; 60(2):250-8.
    View in: PubMed
    Score: 0.015
  33. Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol. 2003 Mar; 41(3):474-80.
    View in: PubMed
    Score: 0.014
  34. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest. 2002 Dec; 110(11):1729-38.
    View in: PubMed
    Score: 0.014
  35. Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2003 Jan; 284(1):H133-40.
    View in: PubMed
    Score: 0.014
  36. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke. 2001 Apr; 32(4):980-6.
    View in: PubMed
    Score: 0.013
  37. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation. 2000 Dec 19; 102(25):3104-10.
    View in: PubMed
    Score: 0.012
  38. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest. 2000 Jul; 106(1):15-24.
    View in: PubMed
    Score: 0.012
  39. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J Cereb Blood Flow Metab. 2000 Apr; 20(4):709-17.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.